| 摘要 |
A process of biogenesis of L-Lysine from e-caprolactam or e-caprolactam degradation or related intermediates selected from e-Amino Caproic Acid (AC A), Amino Adipic Acid, Adipic Acid, Norlecucine or any combinations thereof, by microorganisms or their enzymes, and more particularly microorganisms belonging to groups selected from Alcaligenes spp., Arthrobacter spp., Bacillus spp., Pseudomonas spp. and Rhodococcus spp., in a reaction medium is provided. The biotransformation process is performed leading to biogenesis of L-Lysine from e-caprolactam or e-caprolactam degradation or related intermediates selected from e-Amino Caproic Acid (AC A), Amino Adipic Acid, Adipic Acid, Norlecucine or any combinations thereof, in presence of any or combinations of modulators or inhibitors, and then isolating the L-Lysine from the reaction mixture. A process of biogenesis of L-Lysine from e-caprolactam or e-caprolactam degradation or related intermediates selected from e-Amino Caproic Acid [ACA], Amino Adipic Acid, Adipic Acid, NorLeucine or any combinations thereof, by microorganisms or their enzymes, and more particularly microorganisms belonging to groups Alcaligenes spp., Arthrobacter spp., Bacillus spp., Pseudomonas spp. and Rhodococcus spp.; in a reaction medium. The biotransformation process is performed leading to biogenesis of L-Lysine from e-caprolactam or e-caprolactam degradation or related intermediates selected from e-Amino Caproic Acid [ACA], Amino Adipic Acid, Adipic Acid, NorLeucine or combination thereof, in presence of any or combination of modulators/ inhibitors, and then isolating the L-Lysine from the reaction mixture. |
